FDA expands pirtobrutinib into first-line CLL/SLL for adults without 17p deletion, delivering major PFS gains versus ...

FDA authorized frontline pirtobrutinib for previously untreated CLL/SLL without known 17p deletion, expanding use beyond its established relapsed/refractory setting after covalent BTK inhibition.

Time to worsening of symptoms was improved with amivantamab plus chemotherapy compared with chemotherapy alone in the phase 3 ...

Darius Robinson is no longer a starter. According to the team's first depth chart, the Arizona Cardinals have benched the former first-round pick in favor of Dante Stills. It's a move we called ...

Advertising disclosure: When you use our links to explore or buy products we may earn a fee, but that in no way affects our editorial independence. Frontline provides specialized homeowners insurance ...

The U.S. economy may appear vibrant, based on headlines about the low unemployment rate, the slow pace of layoffs, an apparent slowdown in inflation and the stock market hitting record highs. But ...

- KOMZIFTI - (ziftomenib) generated $9.1 million in net product revenue, up 57% over 1Q, and approximately 115 new patient starts, up 35% over 1Q - - KOMZIFTI achieved majority share of new patient ...

The panel discusses ipilimumab dosing and the management of immune-related toxicity with nivolumab plus ipilimumab in advanced hepatocellular carcinoma (HCC). The panel discusses ipilimumab dosing and ...

The recommended dosage schedule for Foundayo (orforglipron) is one tablet per day. Unlike some similar glucagon-like peptide-1 (GLP-1) medications, you can take Foundayo at any time of day, with or ...

Frontline employees shape the customer experience, spot operational friction first, and determine whether new tools improve work or simply create more of it. Their motivation, judgment, and skill are ...